Ann: Midkine Symposium Munich, page-30

MajorJohnny you incorrectly paraphrase me as stating the CDY report is disappointing...it is not and very far from it. 

I have very high regard of both Co's Management and their underlying strategy and execution.  I am keen, as I've stated many times some more information on the Mk portfolio would be good however i recognise the secrecy needed in this competitive Biotech space.

I have little interest in the current SP as it is not relevant to my strategy at this stage.  ie I am accumulating both.

If you think the CEO should be removed then you can have this raised as an agenda item at the AGM/GM and I look forward to meeting you there.

No I am not "Deep" in the red..just a little atm and green with SEN (just).

The Board are growing the company and similarly would like to see a much greater SP however there mandate is not to pump the SP rather develop the company which they are doing admirably imo.  If you disagree then good for you.